fumarato de l-carnitina Polvo CarniFe ππ©Έ Formulado con L-Carnitina
Description
Off-label use must be prescribed and supervised by a licensed provider
However, it is now recognized that development and progression of AD is likely due to multiple etiologies, and there is increasing evidence implicating oxidative stress (OS) as an early event in the trajectory of MCI and AD [2, 18, 75]
Consistent use is recommended for best results
Xia Y, Chen R, Lu G, et al
